SCHEMBL19865040

SCHEMBL19865040

Cn1nccc1-c1cccc(NC(=O)N2c3nc(-c4cccc(C(F)(F)F)c4)ccc3N3CCC2CC3)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ ATM Q13315 1/20 0.37
▸ NPY2R P49146 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KLRK1 P26718 1/20 0.35
▸ MICA Q29983 1/20 0.35
▸ RAET1L Q5VY80 1/20 0.35
▸ KIF18A Q8NI77 1/20 0.35
▸ HTR2A P28223 2/20 0.35
▸ HTR2C P28335 2/20 0.35
▸ IDH2 P48735 2/20 0.35
▸ CNR1 P21554 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ KARS1 Q15046 1/20 0.34
▸ SCD O00767 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16249961 0.96 IRAK4 (0.37) IRAK4NPC1SMN1; SMN2SCN9AATM
Trifluoroacetic Acid SCHEMBL16238266 0.93 IRAK4 (0.36) IRAK4NPC1SMN1; SMN2SCN9AATM
SCHEMBL19365392 0.84 IDH2 (0.38) NPY2RMEN1ALDH1A1KMT2AIDH2
SCHEMBL16775953 0.84 TRPV1 (0.44) SMN1; SMN2SCN9ANPY2RMEN1ALDH1A1
SCHEMBL16238615 0.84 FAAH (0.41) SMN1; SMN2SCN9ANPY2RMEN1ALDH1A1
SCHEMBL16249976 0.84 RHOA (0.39) NPC1NPY2RMEN1ALDH1A1KMT2A
SCHEMBL17624529 0.82 KIT (0.39) SCN9AHTR2AHTR2CIDH2
SCHEMBL16776220 0.82 PHGDH (0.48) SMN1; SMN2MEN1KMT2A
SCHEMBL20632032 0.82 SCN9A (0.40) IRAK4NPC1SMN1; SMN2SCN9AATM
SCHEMBL16775962 0.82 CA2 (0.40) NPC1SMN1; SMN2NPY2RMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044338-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044338-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 IRAK4 3208/4885NPC1 3776/4885SMN1; SMN2 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback